MYRIAD GENETICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
MYRIAD GENETICS, INC. (MYGN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$38.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-24
- MYRIAD GENETICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$38.80M.
- MYRIAD GENETICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$15.60M.
- MYRIAD GENETICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$52.60M.
- MYRIAD GENETICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$3.00M, a 193.75% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$38.80M 10-K · filed 2026-02-24 | ||
| 2024-12-31 | -$15.60M 10-K · filed 2026-02-24 | ||
| 2023-12-31 | -$52.60M 10-K · filed 2026-02-24 | ||
| 2022-12-31 | -$3.00M 10-K · filed 2025-02-28 | ||
| 2021-12-31 | $3.20M 10-K · filed 2024-02-28 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | ||
| 2020-06-30 | -$3.50M 10-K · filed 2023-03-01 | ||
| 2019-06-30 | $200.00K 10-K · filed 2022-02-25 | ||
| 2018-06-30 | -$500.00K 10-KT · filed 2021-03-16 | ||
| 2017-06-30 | -$3.00M 10-K · filed 2019-08-13 | -$3.10M 10-K · filed 2017-08-09 | |
| 2016-06-30 | -$2.20M 10-K · filed 2018-08-24 | ||
| 2015-06-30 | $8.00M 10-K · filed 2017-08-09 | ||
| 2014-06-30 | -$3.50M 10-K · filed 2016-08-10 | -$3.44M 10-K · filed 2014-08-13 | |
| 2013-06-30 | -$1.60M 10-K · filed 2015-08-12 | -$1.60M 10-K · filed 2013-08-14 | |
| 2012-06-30 | -$1.85M 10-K · filed 2014-08-13 | ||
| 2011-06-30 | $35.02M 10-K · filed 2013-08-14 | ||
| 2010-06-30 | $70.91M 10-K · filed 2012-08-15 | ||
| 2009-06-30 | $28.31M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |